dppe

DPPE-PEG550 serves as a PEG lipid functional terminal group used for synthesizing liposomes (LPs) to design conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) are capable of further coupling with other biomolecules through biotin modification and carboxyl terminals. Functionalized nanoparticles can target specific cell proteins for labeling purposes. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind with biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

DPPE-PEG750 is a PEG lipid functional end group used for synthesizing liposomes (LPs) and designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) modified with biotin and carboxylic ends can couple with other biomolecules. These functionalized nanoparticles are useful for targeting specific cell proteins. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, facilitating fluorescence-based imaging and sensing applications.

DPPE-PEG1000 is a PEG lipid functional end group used for synthesizing liposomes (LPs) and is instrumental in designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs), featuring biotin modification and carboxyl terminals, can further couple with other biomolecules. These functionalized nanoparticles are useful for the targeted labeling of specific cell proteins. By employing streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

DPPE-PEG3000 is a PEG lipid functional end group used for synthesizing liposomes (LPs) and designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) modified with biotin and having a carboxylate end can further couple with other biomolecules. The functionalized nanoparticles are applicable for targeted labeling of specific cell proteins. Using streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can interact with biotinylated antibodies on cell surface receptors, facilitating fluorescence-based imaging and sensing applications.

DPPE-PEG5000 is a PEG lipid functional terminal group utilized for synthesizing liposomes (LPs) and designing conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) with biotin modification and carboxyl ends can further couple with other biomolecules. These functionalized nanoparticles target specific cellular proteins for labeling. Using streptavidin as a linker, the biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

DPPE-PEG1-azide (DPPE-PEG1-N3) is a PEG-modified lipid featuring an azide group (azide). It can participate in copper-catalyzed azide-alkyne cycloaddition reactions (CuAAC) with molecules containing alkyne groups. Additionally, it can undergo strain-promoted alkyne-azide cycloaddition reactions (SPAAC) with molecules that have DBCO or BCN groups.

DPPE-PEG5-azide (DPPE-PEG5-N3) is a PEGylated lipid featuring an azide group (azide). This compound participates in copper-catalyzed azide-alkyne cycloaddition reactions (CuAAc) with molecules containing alkyne groups. Additionally, it engages in strain-promoted azide-alkyne cycloaddition reactions (SPAAC) with molecules that have DBCO or BCN groups.

DPPE-PEG350 is a PEG lipid-functional end group utilized in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. These liposome nanoparticles (LNPs) feature biotin modifications and carboxyl end groups, allowing further coupling with other biomolecules. Functionalized nanoparticles are employed for targeted labeling of specific cellular proteins. Using streptavidin as a linker, biotinylated PEG-lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, enabling applications in fluorescence-based imaging and sensing.

DPPE-PEG2000 (16:0 PEG2000 PE) is a PEG-modified lipid known for reducing nonspecific protein adsorption and extending circulation time in vivo.

DPPE-PEG-amine (MW 2000) is a type of phospholipid. Phospholipids possess excellent biocompatibility and distinct amphiphilic properties, making them suitable and prominent excipients or formulations in drug delivery for enhancing therapeutic outcomes. DPPE-PEG-amine (MW 2000) is applicable in studies related to drug delivery.

m-PEG-DPPE (MW 2000) is a PEG lipid that enhances the delivery efficiency and tissue specificity of poorly soluble drugs. It is applicable for research in drug delivery studies.

DPPE-PEG2-mal is an amphiphilic phospholipid-modified polymer suitable for creating lipid nanoparticles or liposomes for targeted drug delivery applications.

mPEG-DPPE (MW 1000) is an amphiphilic phospholipid-modified polymer that can be utilized in the formulation of lipid nanoparticles or liposomes for targeted drug delivery applications.

N-Linoleoyl-DPPE ammonium is a type of N-acyl phosphatidylethanolamine (NAPE).

N-Palmitoyl-DPPE (triethylammonium) is an N-acyl phosphatidylethanolamine (NAPE) lipid, serving as a palmitic acid derivative of dipalmitoylphosphatidylethanolamine (DPPE).

mPEG-DPPE (MW 5000) is an amphiphilic phospholipid-modified polymer employed in forming lipid nanoparticles or liposomes for targeted drug delivery applications.

N-Stearoyl-DPPE ammonium is a type of N-acyl phosphatidylethanolamine (NAPE). It serves as a crucial intermediate in the biosynthesis pathway of endocannabinoids.

PDP-PEG-NH2 (MW 600) (OPSS-PEG-NH2 (MW 600)) is a PEG derivative useful in research applications such as drug delivery.

PDP-PEG-NH2 (MW 2000) [OPSS-PEG-NH2 (MW 2000)] is a PEG derivative that can be used in research related to drug delivery.

PDP-PEG-NH2 (MW 400) [OPSS-PEG-NH2 (MW 400)] is a PEG-based derivative employed in research fields such as drug delivery.

PDP-PEG-NH2 (MW 5000) [OPSS-PEG-NH2 (MW 5000)] is a PEG derivative that can be utilized in research related to drug delivery.

PDP-PEG-NH2 (MW 1000) (OPSS-PEG-NH2 (MW 1000)) is a PEG derivative utilized in research, including drug delivery studies.

PDP-PEG-NH2 (MW 10000) [OPSS-PEG-NH2 (MW 10000)] is a PEG derivative suitable for research in drug delivery.

PDP-PEG-NH2 (MW 3400) [OPSS-PEG-NH2 (MW 3400)] is a PEG derivative that can be utilized in research related to drug delivery.